Enanta Pharma Q4 Earnings Assessment

Benzinga · 11/25 21:45

The Q4 earnings report for Enanta Pharma (NASDAQ:ENTA) was released on Monday, November 25, 2024 at 04:01 PM.

Here's what investors need to know about the latest announcement.

Earnings

Enanta Pharma beat estimated earnings by 4.0%, reporting an EPS of $-1.36 versus an estimate of $-1.41.

Revenue was down $4.33 million from the same period last year.

Previous Earnings Records

During the previous quarter, the company beat on EPS by $0.38, leading to a 1.0% increase share price change the next day.

Here's a look at Enanta Pharma's past performance:

Quarter Q3 2024 Q2 2024 Q1 2024 Q4 2023
EPS Estimate -1.45 -1.33 -1.19 -2
EPS Actual -1.07 -1.47 -1.58 -1.33
Revenue Estimate 17.18M 16.52M 21.28M 17.50M
Revenue Actual 17.97M 17.05M 18.00M 18.93M

To track all earnings releases for Enanta Pharma visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.